Microbial systems, fill/finish or vaccines? Avid eyeing up bolt-on services
Avid Bioservices says it is looking to expand its biomanufacturing offering as it transitions into a pure-play CDMO from Peregrine Pharmaceuticals.
Avid Bioservices says it is looking to expand its biomanufacturing offering as it transitions into a pure-play CDMO from Peregrine Pharmaceuticals.
Lonza has confirmed it will manufacture gene therapy delivery vectors for hearing and balance disorder-focused biotech Akouos.
The US FDA has approved Admelog as a follow-on drug five months after it received European market authorisation as a biosimilar of Eli Lilly’s Humalog (insulin lispro).
The world’s largest single bioproduction plant has received its first EU regulatory approval to make a monoclonal antibody, says CDMO Samsung Biologics.